A letter to President Bush

July 23, 2001

Sunday, July 15, 2001

The White House
Washington D.C.
President George W. Bush

Dear President Bush,

I am a spinal cord injury researcher and have been deeply concerned by the delays in the decision to allow the National Institutes of Health (NIH) to fund human embryonic stem cell research. I believe, as do the vast majority of my fellow neuroscientists, that human embryonic stem cell research is key to many important therapies that will restore function to people with spinal cord injury and other neurological disorders. I also believe that a decision to allow NIH to fund human embryonic research will markedly reduce the currently unbridled use of embryos and fetuses by private companies.

Please accept my sincere compliments and applause for your thoughtful attempts to find reasonable compromises to this difficult situation. Several weeks ago, I understood that you were considering a compromise where NIH would be allowed to fund human embryonic stem cell research that utilizes only already-established cell lines and to have a sunset clause on the rule such that the embryonic stem cell research can be stopped when adult stem cells become available for research and therapy.

This compromise may satisfy some who are opposed to human embryonic stem cell research but, in my opinion, will be unacceptable to many patient advocacy groups for the following reasons. First, it is not clear that we currently have enough and appropriate embryonic stem cell lines. There are probably thousands of different kinds of stem cells and the existing ones may not be suitable for all diseases. Second, a sunset clause, particularly if it is a short period of 3-5 years, would be too restrictive because there are no guarantees that human adult stem cell work will have progressed far enough in such a short time to substitute for embryonic stem cells.

Therefore, I would like to suggest the following alternative compromise which I believe would be acceptable to many of my colleagues and people that I know with spinal cord injury:

1. NIH be allowed to fund human embryonic stem cell research, but only with existing or NIH- and FDA-certified stem cells. If any researcher wants to utilize new embryonic stem cell lines created after the rule change, they must prove to an NIH committee that they cannot obtain the cells from existing cell lines or that existing cell lines do not possess the characteristics for treating particular disorder. Of course, stem cell use in humans must be approved by the FDA.

2. The rule be allowed to lapse in 10 years (a more reasonable period than 3-5 years) but only if NIH funding for adult stem cell research is boosted substantially to ensure that adult stem cells will be available for research and therapy in 10 years. There is strong support in Congress for an increase in funding of adult human stem cell research.

The above compromise will minimize the current unnecessary and uncontrolled destruction of human embryos for research and therapy. There are currently no laws that forbid isolation of stem cells from embryos or fetuses by private companies. Many companies are rushing to take advantage of the governmental indecision on this matter. At least three companies have announced that they are obtaining sperm and eggs from human volunteers to produce embryos for the purpose of creating stem cells. Undoubtedly, other companies are doing the same but are not announcing their work. If an NIH-and FDA- certified source of embryonic stem cells were available and became the standard, I believe that it will be a strong deterrent to the currently unmonitored and widespread use of human embryos and fetuses to produce stem cells. Time is of the essence in this matter.

Thank you very much for your time and attention.

Sincerely,
Wise Young, Ph.D., M.D.
-end-
Wise Young, Ph.D., M.D., Professor II and Director
W. M. Keck Center for Collaborative Neuroscience
Rutgers, The State University of New Jersey
Piscataway, New Jersey

Rutgers University

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.